Loading...
Effect of filgotinib, a selective JAK 1 inhibitor, with and without methotrexate in patients with rheumatoid arthritis: patient-reported outcomes
BACKGROUND: The aim was to assess patient-reported outcomes (PROs) in patients with rheumatoid arthritis (RA) treated with filgotinib during two phase 2b, 24-week, randomized, placebo-controlled studies. METHODS: Patients with moderate-to-severe active RA and an inadequate response to methotrexate (...
Na minha lista:
| Udgivet i: | Arthritis Res Ther |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5865354/ https://ncbi.nlm.nih.gov/pubmed/29566740 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13075-018-1541-z |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|